Light Sheet Microscopy Using FITC-Albumin Followed by Immunohistochemistry of the Same Rehydrated Brains Reveals Ischemic Brain Injury and Early Microvascular Remodeling.
angiography
brain clearing
capillary
cerebral microvessels
focal cerebral ischemia—reperfusion
ischemic stroke
microvascular remodeling
Journal
Frontiers in cellular neuroscience
ISSN: 1662-5102
Titre abrégé: Front Cell Neurosci
Pays: Switzerland
ID NLM: 101477935
Informations de publication
Date de publication:
2020
2020
Historique:
received:
03
11
2020
accepted:
07
12
2020
entrez:
20
1
2021
pubmed:
21
1
2021
medline:
21
1
2021
Statut:
epublish
Résumé
Until recently, the visualization of cerebral microvessels was hampered by the fact that only short segments of vessels could be evaluated in brain sections by histochemistry. These limitations have been overcome by light sheet microscopy, which allows the 3D analysis of microvasculature in cleared brains. A major limitation of light sheet microscopy is that antibodies do not sufficiently penetrate cleared brains. We herein describe a technique of reverse clearing and rehydration, which after microvascular network analysis allows brain sectioning and immunohistochemistry employing a broad set of antibodies. Performing light sheet microscopy on brains of mice exposed to intraluminal middle cerebral artery occlusion (MCAO), we show that in the early phase of microvascular remodeling branching point density was markedly reduced, more strongly than microvascular length. Brain infarcts in light sheet microscopy were sharply demarcated by their autofluorescence signal, closely corresponding to brain infarcts revealed by Nissl staining. Neuronal survival, leukocyte infiltration, and astrocytic reactivity could be evaluated by immunohistochemistry in rehydrated brains, as shown in direct comparisons with non-cleared brains. Immunohistochemistry revealed microthrombi in ischemic microvessels that were likely responsible for the marked branching point loss. The balance between microvascular thrombosis and remodeling warrants further studies at later time-points after stroke.
Identifiants
pubmed: 33469420
doi: 10.3389/fncel.2020.625513
pmc: PMC7813928
doi:
Types de publication
Journal Article
Langues
eng
Pagination
625513Informations de copyright
Copyright © 2021 Mohamud Yusuf, Hagemann, Schulten, Rausch, Wagner, Hussner, Qi, Totzeck, Kleinschnitz, Squire, Gunzer and Hermann.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Cell. 2016 Jun 16;165(7):1789-1802
pubmed: 27238021
Stroke. 1991 Oct;22(10):1276-83
pubmed: 1926239
Nat Methods. 2020 Apr;17(4):442-449
pubmed: 32161395
Stroke. 2018 Oct;49(10):2495-2503
pubmed: 30355106
J Cereb Blood Flow Metab. 2009 Oct;29(10):1620-43
pubmed: 19654590
Trends Neurosci. 2019 Aug;42(8):528-536
pubmed: 31255380
Cell. 2016 Jun 16;165(7):1776-1788
pubmed: 27238022
J Cereb Blood Flow Metab. 2017 Oct;37(10):3355-3367
pubmed: 28350253
Ann Neurol. 2015 May;77(5):784-803
pubmed: 25628066
Nat Commun. 2020 Apr 27;11(1):1982
pubmed: 32341345
J Neurosci. 2009 Nov 18;29(46):14553-70
pubmed: 19923289
Nat Neurosci. 2015 Oct;18(10):1518-29
pubmed: 26368944
Lancet Neurol. 2012 Apr;11(4):369-80
pubmed: 22441198
Stroke. 2020 Jun;51(6):1825-1834
pubmed: 32312217
J Appl Physiol (1985). 1999 Apr;86(4):1211-9
pubmed: 10194205
Nat Commun. 2019 May 24;10(1):2312
pubmed: 31127113
J Neuroinflammation. 2017 Jan 21;14(1):18
pubmed: 28109273
Sci Rep. 2018 Jan 26;8(1):1647
pubmed: 29374186
Br J Pharmacol. 2010 Aug;160(7):1577-9
pubmed: 20649561
Cell. 2020 Feb 20;180(4):780-795.e25
pubmed: 32059781
Cell. 2014 Nov 6;159(4):896-910
pubmed: 25417164